康泰医学（300869）8月5日主力资金净流出3429.36万元

Group 1 - The core viewpoint of the news is that 康泰医学 (Kangtai Medical) has shown a significant increase in its financial performance, with notable growth in revenue and net profit for the first quarter of 2025, despite a decline in stock price on the reporting date [1][3] - As of August 5, 2025, 康泰医学's stock closed at 19.51 yuan, down 5.01%, with a turnover rate of 10.9% and a trading volume of 276,200 hands, amounting to a transaction value of 549 million yuan [1] - The company reported total operating revenue of 112 million yuan for Q1 2025, representing a year-on-year increase of 12.77%, and a net profit attributable to shareholders of 16.44 million yuan, up 277.67% year-on-year [1] Group 2 - The company's non-recurring net profit reached 13.77 million yuan, reflecting a substantial year-on-year growth of 515.19% [1] - Financial ratios indicate a current ratio of 12.442, a quick ratio of 10.900, and a debt-to-asset ratio of 32.77%, suggesting strong liquidity and financial stability [1] - 康泰医学 has made investments in 6 companies, participated in 413 bidding projects, and holds 68 trademark registrations and 618 patents, along with 101 administrative licenses [2]